Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pioglitazone hydrochloride p-aminosalicylic acid eutectic crystal, preparation method, composition and application thereof

A technology of pioglitazone hydrochloride and p-aminosalicylic acid, which is applied in the field of medicine, can solve the problems of no pioglitazone hydrochloride eutectic patents or literature reports, low dissolution rate, low dissolution rate, etc., and achieve the effect of significant biological absorption advantages

Pending Publication Date: 2022-01-18
INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Pioglitazone hydrochloride is almost insoluble in water and belongs to insoluble medicine. At present, pioglitazone hydrochloride is mainly used as oral tablet, which has the disadvantages of low dissolution rate, low dissolution rate and low bioavailability
[0006] According to domestic and foreign patent and literature searches, no other eutectic patents or literature reports related to pioglitazone hydrochloride have been found

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pioglitazone hydrochloride p-aminosalicylic acid eutectic crystal, preparation method, composition and application thereof
  • Pioglitazone hydrochloride p-aminosalicylic acid eutectic crystal, preparation method, composition and application thereof
  • Pioglitazone hydrochloride p-aminosalicylic acid eutectic crystal, preparation method, composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] Preparation method 1 of pioglitazone hydrochloride and p-aminosalicylic acid cocrystal:

[0061] According to the table below, take appropriate amount of pioglitazone hydrochloride and p-aminosalicylic acid (molar ratio 1:1) into a mortar, add appropriate amount of organic solvent, manually grind for an appropriate time, and dry at a certain temperature. Carry out powder X-ray diffraction analysis to it, its diffraction pattern and figure 1 Consistent, show that the obtained sample is pioglitazone hydrochloride and p-aminosalicylic acid eutectic.

[0062] Table 3 The experimental conditions example of pioglitazone hydrochloride and p-aminosalicylic acid cocrystal preparation method 1

[0063]

[0064] Preparation method 2 of pioglitazone hydrochloride and p-aminosalicylic acid cocrystal:

[0065] As shown in the table below, put appropriate amount of pioglitazone hydrochloride and p-aminosalicylic acid (molar ratio 1:1) into a ball mill jar, add an appropriate amou...

Embodiment 2

[0073] Solubility characteristics of pioglitazone hydrochloride and p-aminosalicylic acid co-crystal:

[0074] Pioglitazone hydrochloride belongs to the poor medicine of water solubility, uses 0.2% SDS aqueous solution to carry out experiment, solvent system has significant difference to the dissolution rate of pioglitazone hydrochloride and p-aminosalicylic acid cocrystal and two kinds of substances of pioglitazone hydrochloride (f 2 =26.23)( Figure 6 ). Determination with reference to the solubility determination method ("Technical Guidelines for Dissolution Test of Ordinary Oral Solid Preparations (First Draft)", 2012, October Center for Drug Evaluation). Adopt high performance liquid chromatography, utilize the chromatographic peak area data of sample to calculate the concentration of sample dissolution, take time as abscissa, and solvent concentration as ordinate to draw solubility curve respectively, and data are as shown in the following table:

[0075] The dissoluti...

Embodiment 3

[0080] The absorption characteristics and plasma concentration characteristics of pioglitazone hydrochloride and p-aminosalicylic acid co-crystal in rats:

[0081] SD rats were randomly divided into groups, 5 in each group, free to drink water, and after fasting for 12 hours, the weight of the rats was weighed, according to 20 mg·kg -1 Pioglitazone hydrochloride dosage calculation, pioglitazone hydrochloride and pioglitazone hydrochloride and p-aminosalicylic acid eutectic samples are packed in the solid dispenser, and the powder is directly inserted into the stomach of rats through the oral cavity. At 15min, 30min, 1h, 1.5h, 2h, 2.5h, 3h, 4h, 6h, 8h, 10h, 12h, 24h, 36h after administration, blood was taken from the inner canthus of the eye and placed in a heparinized tube. Centrifuge at 6500rpm for 10min, and freeze in a -40°C refrigerator until testing. Precisely draw 40 μL of heparin-anticoagulated plasma, put it in a 1.5 mL centrifuge tube, add 10 μL of internal standard ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine, and discloses a piolitazone hydrochloride p-aminosalicylic acid eutectic crystal, a preparation method, a pharmaceutical composition and application thereof, specifically a piolitazone hydrochloride and p-aminosalicylic acid eutectic crystal solid substance state, a preparation method of a piolitazone hydrochloride and p-aminosalicylic acid eutectic crystal solid substance sample, and application of the piolitazone hydrochloride and p-aminosalicylic acid eutectic crystal substance as an active ingredient in peparation of drugs for reducing blood sugar and blood fat and relieving or preventing diabetic nephropathy and insulin cell degeneration.

Description

technical field [0001] The invention discloses a cocrystal of pioglitazone hydrochloride and p-aminosalicylic acid, a preparation method, a composition and an application thereof. Specifically, the present invention discloses a cocrystal formed by pioglitazone hydrochloride and p-aminosalicylic acid; a preparation method of pioglitazone hydrochloride and p-aminosalicylic acid cocrystal; pioglitazone hydrochloride and p-aminosalicylic acid cocrystal as The application of pharmaceutical active ingredients in the preparation of medicines for lowering blood sugar, lowering blood fat, alleviating or preventing diabetic nephropathy and insulin cell degeneration belongs to the field of medical technology. Background technique [0002] Pharmaceutical co-crystals refer to the crystals formed by intermolecular non-covalent interaction forces between active drug molecules and co-crystal formers in a certain ratio. By forming co-crystals, drugs can greatly enrich their crystalline form...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D417/12C07C229/60C07C227/42A61K31/4439A61P3/10A61P3/06A61P13/12A61P5/50
CPCC07D417/12C07C229/60A61P3/10A61P3/06A61P13/12A61P5/50C07B2200/13
Inventor 吕扬杜冠华宋俊科龚宁波王英杨世颖孔德文梁宇张丽赵晓悦
Owner INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com